Vaccine Delivery Devices Market By Product Type (Syringes, Jet Injectors, Micro Needles, Aerosol/Dry Powder Inhalation, Intranasal Delivery Devices, Intradermal Delivery Devices) By Route of Administration (Intradermal, Intramuscular, Subcutaneous, Others) By End Users (Hospitals, Clinics, Others) : Market Growth, Future Prospects & Competitive Analysis, 2016-2028

About this report

The global Vaccine Delivery Devices Market report explores the critical analysis of the vaccine delivery devices industry using key parameters. The report consists of investment strategies, the need for investments in the vaccine delivery devices industry, and the multiple benefits for the investors. Importantly, this report sets out major changes in the global technical regulations for the vaccine delivery devices industry and how economic and non-economic barriers are helping the market grow. Moreover, the report analyses the global, regional, and country-level historic and forecasted market size. The report also provides a comprehensive analysis of key investment propositions, demand and supply gap, competitors positioning, STAR analysis, SRC analysis, and Tornado analysis. Key technological developments and other analyses such as porter's five forces analysis, PESTEL analysis, value chain analysis, etc.


Key Highlights of the report

How are the major segments performing in the Vaccine Delivery Devices Market?

In terms of product type, the syringes segment led the market in 2021. Vaccines are most commonly administered using syringes. They are frequently utilized in mass vaccination and routine immunization programs due to their low cost and high effectiveness. Syringes that are new and technologically sophisticated, like auto-disposable and prefilled syringes, are becoming more and more common.

The intradermal route of the administration segment held the largest market share in 2021, and this trend is expected to continue throughout the projection period. Due to advantages like dose sparing, enhanced safety, and easier access to vaccines, this vaccine delivery method has gained attention in recent years. The segment is also expected to be driven by increased research on alternate intradermal administration techniques using cutting-edge tools like jet injectors and microneedles.

The hospital segment shares the highest market share in the end-user category in 2021. The segment's growth can be attributed to the high use of vaccine delivery in hospitals and rising demand.

Which region dominated the Vaccine Delivery Devices Market?

North America dominated the vaccine delivery devices market in 2021 and is expected to continue its dominance over the forecast period. Increased R&D investments for new vaccines, growing immunization coverage, and the high prevalence of infectious diseases drive regional market growth. Moreover, developed healthcare infrastructure and widespread public and professional awareness have contributed to the market's large share. The presence of important regional players further accelerates significant market expansion. According to a European Commission report published in 2021, the U.S. controls the majority of vaccine research and development.

What is the competitive environment of the Vaccine Delivery Devices Market?

The vaccine delivery devices industry's competitive environment offers information on the total economic profit made by suppliers and businesses, the sales and revenues produced in this sector, the vaccine delivery devices market share globally, the business organization overview, the introduction of new products, and the opportunities for the industrial vaccine delivery devices market. Leading companies invest heavily in R&D and launching new products to capture a larger global market share. For instance, Gerresheimer and Midas Pharma announced a strategic partnership in November 2021. Their collaborative project entails the design and marketing of a new generation autoinjector. On the other hand, in May 2020, PharmaJet and Abnova agreed to collaborate on developing and delivering the COVID-19 mRNA vaccine via needle-free injection technology.

Executive Summary

What are all technical developments being developed in the Vaccine Delivery Devices Market?

Developing novel drug delivery technologies and investing in vaccine research drive the vaccine delivery device market. For instance, Gerresheimer and Portal teamed up in May 2022 to treat patients with chronic illnesses using a needle-free medication delivery system. The United States-based developer of cutting-edge needle-free medicine delivery technology, Portal Instruments, has received funding from Gerresheimer. The partners plan to change how injectable drugs are administered to enhance the patient experience. Portal develops technology that allows for high-speed, needle-free subcutaneous injection of medicine and patient and medical care provider adherence tracking throughout the treatment path through connectivity. Novel and technologically advanced syringes, like auto-disposable and prefilled syringes, are gaining popularity. The increasing interest of key players and various international organizations and institutions in novel delivery technologies such as jet injectors and microneedles is also expected to drive the market.

Which are the key investments by the players in the Vaccine Delivery Devices Market?

Increased investment in R&D to bring new vaccination technologies to market is expected to drive market growth during the forecast period. Various investments are made among the key player. For instance, in December 2020, US-based Becton, Dickinson, & Company reached a 2 billion injection device milestone supporting global COVID-19 vaccination efforts. They are spending USD 1.2 billion over four years to upgrade manufacturing technology for pre-fillable syringes and advanced drug delivery systems, in addition to helping with the initial COVID-19 vaccine preparations. This will enable the development of new injectable medications and vaccines while offering surge capacity for increased pre-fillable syringe supply during the pandemic response. On the other hand, the U.K. government also announced funding for up to one million euros through the Medical Research Council from its Global Challenges Research Fund to study the Zika virus and its spread.

Some of the major players in the market are Panacea Pharmaceuticals, 3 M, Bioject Medical Technologies, PharmaJet, Valeritas, Vaxxas, Gerresheimer, Schott AG, Corium International, and Becton Dickinson & Company.   

What are the Major Driving Factors for the Vaccine Delivery Devices Market?

Growing immunization programs and their expanding coverage, increased vaccination research, improved government support and investment, progression of novel vaccines, and numerous initiatives and campaigns are key factors driving the market growth. Pharmaceutical and biotech companies collaborate with governments worldwide to develop a strategy for addressing supply chain difficulties in vaccine delivery and developing effective vaccines. The need for an immediate COVID-19 vaccine has sparked interest in developing a safe and efficient viral delivery method or several delivery systems.

What are the Major Risks for the Vaccine Delivery Devices Market?

The rising cost of micro-needles, particularly in emerging markets, is one of the major factors impeding the market growth. Infections are associated with vaccine delivery devices, though the market is growing more quickly. These side effects have the potential to reduce market growth significantly. Untrained professionals who cannot carry out these vaccine administrations will undoubtedly impede market growth during the forecast period.

Which is the key product type in the Vaccine Delivery Devices Market?

Syringes held the largest revenue share by product type in 2021 due to expanding vaccination programs, vaccination coverage, and technological advancements. Syringes are instruments used to inject medicine into or remove fluid from the body. It is most commonly used to administer vaccines to humans. There are various syringe sizes for intramuscular, intravenous, and intradermal administration. Syringes play an important role in the vaccine delivery device market due to their widespread use in hospitals and clinics. They are widely used in immunization and mass vaccination initiatives as they are both inexpensive and effective. Syringes that are novel and technologically advanced, such as auto-disposable and prefilled syringes, are gaining popularity. However, many people fear needles used during syringes due to the pain they cause. Inadequate needle sterilization and reuse raise the risk of infection. Thus, safe, single-use auto-disable syringes are widely used in mass vaccination initiatives. Prefilled syringe use is growing due to several benefits, including increased patient safety, reduced vaccine waste, and operational efficiency.

How is the Vaccine Delivery Devices Market performing in regions?

In 2021, North America dominated the vaccine delivery devices market. Regional market growth is driven by increased R&D investments for new vaccines, increasing immunization coverage, and the high prevalence of infectious diseases. Furthermore, the market's large share is due to developed healthcare infrastructure and widespread public and professional awareness. The presence of significant regional players hastens significant market expansion. According to a report published by the European Commission in 2021, the United States controls the majority of vaccine research and development. According to CDC (Centers for Disease Control and Prevention) data, an estimated 385,000 sharp injuries, including needle stick injuries, occur annually in hospitals in the United States. Increasing vaccine adoption and advancements in vaccine administration are driving market growth. The growing interest in novel delivery technologies among key players, national institutions, and organizations is expected to contribute to regional market growth.

Besides, Asia Pacific is expected to grow fastest during the forecast period, owing to the region's large patient base, rising target population, increased unmet needs, and developing infrastructure. Diseases are becoming more common due to unhealthy lifestyles and an aging population susceptible to infectious diseases. Increased awareness about the benefits of vaccinations and technological infrastructure developments are expected to drive regional market growth. Many regional governments are increasing vaccination spending and demonstrating strong and effective ownership and leadership of immunization programs. Vaccine-preventable diseases are major causes of illness and long-term disability in developing countries such as China and India.

What is the regulatory landscape for the Vaccine Delivery Devices Market?

Initiatives by various regulatory bodies such as WHO, UNICEF, and Gavi are expected to boost market growth. Vaccine-related organizations include the GAVI Alliance, the Bill & Melinda Gates Foundation, and the World Health Organization. Many governments around the world are prioritizing several immunization programs. Moreover, governments in many countries are promoting vaccination campaigns to prevent disorders and deaths from vaccine-preventable diseases. This, combined with increasing investments by non-governmental organizations (NGOs) in vaccination programs and global campaigns, is positively influencing the market.

What is the Market Size of the Vaccine Delivery Devices regarding value?

The global vaccine delivery devices market is anticipated to grow at a substantial CAGR of 8.4% in the upcoming years. The global vaccine delivery devices industry was estimated to be worth USD 3.7 billion in 2021 and was expected to be worth USD 6.0 billion by 2028.

What are the major players planning for the future of the Vaccine Delivery Devices Market?

For the prevention of viral diseases and severe infectious, there is a high demand for products and more effective delivery technologies. In addition, several government organizations and campaigns have increased funding for producing vaccines and delivery devices, expected to drive market growth in the forecast period. Furthermore, future scenarios suggest that well-known market players invest significantly in startups and medium-sized businesses to provide effective solutions to the industry. The major players are expected to acquire or merge with major companies or startups to gain a competitive advantage. For instance, Becton, Dickinson and Company and Mitsubishi Gas Chemical signed a letter of intent (LOI) in May 2022 to discuss forming a partnership to develop an innovative biological drug delivery methodology OXYCAPTTM combines the best of plastic and glass for plastic syringes.

Segmentation of Global Vaccine Delivery Devices Market -

Global Vaccine Delivery Devices Market – By Product Type

  • Syringes
  • Jet Injectors
  • Micro Needles
  • Aerosol/Dry Powder Inhalation
  • Intranasal Delivery Devices
  • Intradermal Delivery Devices

 Global Vaccine Delivery Devices Market – By Route of Administration

  • Intradermal
  • Intramuscular
  • Subcutaneous
  • Others

Global Vaccine Delivery Devices Market – By End Users

  • Hospitals
  • Clinics
  • Others

Global Vaccine Delivery Devices Market – By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • The U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

Frequently asked questions about the global Vaccine Delivery Devices Market

The COVID-19 outbreak has had a favorable effect on the market. The global demand for COVID-19 vaccines created a substantial opportunity for expansion, benefiting the market significantly.

North America accounted for the highest share in the global vaccine delivery devices market in terms of value and volume.

The major factors driving the market growth are rising government support and investment in routine vaccination programs and their increasing coverage, ongoing R&D in vaccination, and numerous campaigns and initiatives.

Syringes had a major share in 2021, with more than 38% of the market revenue share. Besides, jet injectors are projected to witness the fastest growth.

The hospital industry had a major share in the global market in 2021 and is projected to continue its dominance over the forecast period.

Vaccine Delivery Devices Market Scope

Report Attribute Details
Market Value in 2021 USD 3.7 Bn
Market Value in 2028 USD 6.0 Bn
CAGR 8.4%
Benchmarking Year 2021
Past data 2016 – 2021
Forecast period 2022 – 2028
Choose License Type
Trusted By
Published Date:  Sep 2022
Category:  Medical Devices
Report ID:   60644
Report Format:   PDF
Pages:   190
Rating:    4.8 (12)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support